Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aster DM Quality CareNSE:ASTERDM -1.71%73 EV-to-EBIT is 101.89 as of Jul. 23, 2026, which is 417% above its 10-year median of 19.71. GuruFocus rates NSE:ASTERDM with a GF Score™ of 73/100 and a GF Value™ of ₹712.37 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 468 Healthcare Providers & Services companies, Aster DM Quality Care ranks worse than 93.16% on this metric.
The historical rank and industry rank for Aster DM Quality Care's EV-to-EBIT or its related term are showing as below:
NSE:ASTERDM'
s EV-to-EBIT Range Over the Past 10 Years
Min: -1847.08 Med: 19.71 Max: 178.62
Current: 101.88
During the past 12 years, the highest EV-to-EBIT of Aster DM Quality Care was 178.62. The lowest was -1847.08. And the median was 19.71.
NSE:ASTERDM's EV-to-EBIT is ranked worse than 93.16% of 468
companies
in the Healthcare Providers & Services industry
Industry Median: 15.955
vs NSE:ASTERDM: 101.88
Aster DM Quality Care (NSE:ASTERDM) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Aster DM Quality Care's Enterprise Value for the quarter that ended in Mar. 2026 was ₹356,270 Mil.
Aster DM Quality Care's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹6,927 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ASTERDM vs HCA, THC, DVA: EV-to-EBIT Comparison
For the Medical Care Facilities subindustry, Aster DM Quality Care's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aster DM Quality Care EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aster DM Quality Care's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Aster DM Quality Care's EV-to-EBIT falls into.
Aster DM Quality Care's current Enterprise Value is ₹705,748 Mil.
Aster DM Quality Care's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹6,927 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aster DM Quality Care (NSE:ASTERDM) has a EV-to-EBIT of 101.89 as of Jul. 23, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Aster DM Quality Care and its competitors. This is 417% above median its historical median of 19.71. According to the industry distribution chart, Aster DM Quality Care ranks #436 out of 468 companies in the Healthcare Providers & Services industry, placing it in the top 93.2%.
Is Aster DM Quality Care's EV-to-EBIT too high?
Aster DM Quality Care's current EV-to-EBIT of 101.89 is 417% above median its 10-year median of 19.71. The Healthcare Providers & Services industry median EV-to-EBIT is 15.96. Aster DM Quality Care's value of 101.89 is 538.6% above this industry median. Based on the distribution chart, Aster DM Quality Care ranks #436 out of 468 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Aster DM Quality Care has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aster DM Quality Care's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Aster DM Quality Care ranks #436 out of 468 companies for EV-to-EBIT. This places Aster DM Quality Care in the lower half of its industry. The industry median EV-to-EBIT is 15.96. Aster DM Quality Care's value of 101.89 is 538.6% above this benchmark. While the company's 10-year median is 19.71 vs. the industry median of 15.96, Aster DM Quality Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.96, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aster DM Quality Care's current EV-to-EBIT of 101.89 is 538.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Aster DM Quality Care and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aster DM Quality Care's current EV-to-EBIT is 101.89, which is 417% above median its own 10-year median of 19.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aster DM Quality Care stock overvalued right now?
Based on GuruFocus' analysis, Aster DM Quality Care (NSE:ASTERDM) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹712.37, compared to a current price of ₹799.50 — trading 12.2% above its estimated fair value. The current EV-to-EBIT is 101.89, which is 417% above median its 10-year median of 19.71 and 538.6% above the Healthcare Providers & Services industry median of 15.96. Aster DM Quality Care's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Aster DM Quality Care (NSE:ASTERDM), the current EV-to-EBIT is 101.89 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aster DM Quality Care (NSE:ASTERDM) Overvalued in 2026?
Based on GuruFocus' analysis, Aster DM Quality Care stock appears to be overvalued.
The current stock price of ₹799.50 is trading 12.2% above its estimated GF Value™ of ₹712.37.
GuruFocus considers Aster DM Quality Care to be Modestly Overvalued.
Key valuation signals for NSE:ASTERDM:
EV-to-EBIT: 101.89 (417% above median its 10-year median of 19.71)
GF Value™: ₹712.37 vs. price of ₹799.50 (12.2% above fair value)
Industry Position: 538.6% above the Healthcare Providers & Services median (#436 of 468)
No single metric tells the full story. See the NSE:ASTERDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aster DM Healthcare Ltd is an India-based integrated healthcare provider. The group operates a comprehensive healthcare network comprising approximately 19 hospitals, 10 clinics, over 200 pharmacies, and more than 255 diagnostic laboratories across states. Its business segments include Hospitals, Clinics, Retail Pharmacies, and Others, with the majority of revenue derived from the Hospitals segment. Aster has been delivering high-quality care from primary to quaternary through dedicated personnel across clinical and non-clinical roles. Aster has a presence in metropolitan as well as Tier II and Tier III cities, and is committed to providing advanced and accessible healthcare in line with global standards, guided by a patient-first approach.
73GF Score
Get the complete analysis for NSE:ASTERDM
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ASTERDM has been successfully added to your 
